Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04072484 · ClinicalTrials.gov registry record · NA
Effectiveness of Chest Compressions Under Mild Hypoxia
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04072484: Clinical Trial NA study, sponsored by University of Chicago.
NCT04072484 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04072484, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of breathing a slightly reduced amount of oxygen will have on a rescuer's ability to provide chest compressions during CPR.
Primary Outcome
Number of successful two-minute CPR rounds
Interventions
- OTHER Mild hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-08-16 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
Why NCT04072484 stopped before completion
NCT04072484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Mild hypoxia is the first listed.
NCT04072484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04072484 about?
NCT04072484 is a clinical study titled "Effectiveness of Chest Compressions Under Mild Hypoxia". The purpose of this study is to evaluate the effect of breathing a slightly reduced amount of oxygen will have on a rescuer's ability to provide chest compressions during CPR.
What is the current status of trial NCT04072484?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2019-08-16. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT04072484?
The interventions under investigation include: Mild hypoxia (OTHER).
Who is sponsoring clinical trial NCT04072484?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04072484's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI